Experts at ISC 2026 highlighted growing evidence that GLP-1 receptor agonists may reduce stroke risk and support brain health through anti-inflammatory, vascular, and neuroprotective mechanisms.

The procurement and perfusion method, areas that are rapidly evolving, will likely play a role in the success of DCD transplants.

With the study adding to a mix of conflicting trial results, it’s not yet time to update guidelines, Shyam Prabhakaran says.

Apollo Specialty Hospitals in Tiruchi launches advanced CT perfusion scan and stroke command centre for enhanced stroke care ...

Between the simpler approach of ascending aortic hemiarch replacement and a full-on extended arch reconstruction, overall ...

Rapid Medical announces DISTALS trial results showing TIGERTRIEVER 13 achieved superior brain reperfusion with strong safety in MVO ischemic stroke.

Giving the clot-busting medication alteplase at the site of a blocked brain artery after blood clot removal may increase the ...

Caveat in Chinese trial was the increased symptomatic intracranial hemorrhage risk ...

Al Zahra Hospital Dubai has announced the installation of the NAEOTOM Alpha photon-counting computed tomography (CT) system from Siemens Healthineers, marking an important step in expanding its ...

Rapid Medicaltm, a leading developer of active endovascular devices, today announced late-breaking results from the DISTALS multicenter, randomized controlled trial showing that TIGERTRIEVERtm 13 ...

Scientists have taken a decisive step toward ending one of transplant medicine’s most stubborn bottlenecks: the need to match donor organs to a recipient’s blood type. By chemically reengineering a ...